title: Cardioprotective role of statins in chronic kidney disease: do we have the answer?
abstract: The observational study by Szummer et al. shows that patients with advanced chronic kidney disease (CKD) are treated less with statins after myocardial infarction, even though statins benefit survival in CKD classes 1-4. The study's limitations are obvious, but such a population may be more representative. The results indicate that statins should be used more frequently after myocardial infarction in CKD classes lower than 5, a conclusion supported by the recently presented Study of Heart and Renal Protection (SHARP).
authors.affiliation: Department of Nephrology, Uppsala University, Uppsala, Sweden. bengt.fellstrom@medsci.uu.se
authors.forename: Bengt C
authors.initials: BC
authors.lastname: Fellström
mesh_terms: D002908:Chronic Disease; D005919:Glomerular Filtration Rate; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000503:physiopathology*; D009203:Myocardial Infarction / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors